Related Experiment Video
Updated: Jun 17, 2025
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
Controversies in prostate cancer screening.
Daisy Obiora1, Oluwaseun Orikogbo1, Benjamin J Davies1
1Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center.
Urologic Oncology
|August 10, 2024
Summary
Prostate cancer screening has evolved since the introduction of Prostate-Specific Antigen (PSA) testing. This study examines updated recommendations and innovative adjunctive tests for prostate cancer diagnosis.
Area of Science:
- Oncology
- Urology
- Diagnostic Medicine
Background:
- Prostate cancer is a significant global health concern for men.
- Prostate-Specific Antigen (PSA) testing, introduced in the 1980s, dramatically increased prostate cancer diagnoses.
- There is an ongoing need to refine prostate cancer screening methods.
Purpose of the Study:
- To review current clinical recommendations for prostate cancer screening.
- To identify and discuss emerging innovations in adjunctive testing for prostate cancer.
- To provide an overview of the evolving landscape of prostate cancer diagnostics.
Main Methods:
- Literature review of clinical guidelines and recommendations.
- Survey of recent advancements in prostate cancer diagnostic technologies.
- Analysis of trends in prostate cancer screening protocols.
Main Results:
- Significant shifts in screening guidelines have occurred post-PSA implementation.
- New adjunctive tests show promise in improving diagnostic accuracy and reducing unnecessary biopsies.
- Technological innovations are enhancing the specificity and sensitivity of prostate cancer detection.
Conclusions:
- Current prostate cancer screening strategies are dynamic and evolving.
- Adjunctive testing plays a crucial role in refining diagnostic pathways.
- Continued research into innovative screening tools is essential for better patient outcomes.
